Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(2):219-224 | DOI: 10.5507/bp.2007.037

INTRA-ARTERIAL CHEMOTHERAPY AND ITS SIGNIFICANCE IN THE TREATMENT OF OROPHARYNGEAL CARCINOMA

Jiri Simeka, Jiri Ehrmannb, Jindrich Pazderaa
a Oral, Maxillary and Facial Surgery Clinic, Faculty of Medicine and Dentistry and Teaching Hospital, Palacky University Olomouc, Czech Republic
b Department of Pathology, Faculty of Medicine and Dentistry and Teaching Hospital, Palacky University, Olomouc

Background: In complex therapeutic algorithms for cancer, regional intra-arterial chemotherapy is usually used as an adjuvant and placed in the beginning of treatment. Clinical experience however shows that the achieved remission of malignant tumour illness after non-adjuvant chemotherapy is only temporary and short-lived. The illness progresses relatively quickly if the patient receives no further treatment and most clinical studies have not found any significant increase in life expectancy in oncological patients treated with this method. The question remains to what extent the poor results are due to the treatment method and its position in the therapeutic algorithm, and to what extent they are due to imperfect knowledge of molecular tumour genetics or inappropriate choice of the neoadjuvant intra-arterial chemotherapy Methods: We compared preliminary results of immunohistochemical examinations (detection and analysis of expression of proteins Ku 70, STAT 1,3,5 which take part in the regulation of cell cycle apoptosis and repair of damaged DNA, carried out before and after chemotherapy, suggest that depending on the effects of neoadjuvant intra-arterial chemotherapy and patient's survivance.

Results and Conclusion: An overview of intra-arterial neoadjuvant chemotherapy of head and neck is presented. Knowledge of cell cycle processes, especialy apoptosis and repair of damaged DNA, could significantly influence the choice of the therapeutic algorithm and therapeutical effect.

Keywords: Oropharyngeal carcinoms, Intra-arterial chemotherapy

Received: September 3, 2007; Accepted: October 27, 2007; Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Simek, J., Ehrmann, J., & Pazdera, J. (2007). INTRA-ARTERIAL CHEMOTHERAPY AND ITS SIGNIFICANCE IN THE TREATMENT OF OROPHARYNGEAL CARCINOMA. Biomedical papers, 151(2), 219-224. doi: 10.5507/bp.2007.037
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abele R, Honegger HP, Grossenbacher R, Mermillod B, Kaplan E, Gervasi A et al. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck European Journal of Cancer & Clinical Oncology 1987; 23(1):4753. Go to original source...
    2. Adelstein D, LeBlanc M. Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer? Journal of Clinical Oncology 2006; 24(17):26242628. Go to original source... Go to PubMed...
    3. Advani SH, Gopal R, Saikia T, Pai VR. Induction chemotherapy in head and neck cancer: present status and future. Seminars in Surgical Oncology 1989; 5(5):33740. Go to original source... Go to PubMed...
    4. Argiris A, Jayaram P, Pichardo D. Revisiting induction chemotherapy for head and neck cancer: References and reviews. Oncology (Huntington) 2005; 19(7):932-934+939.
    5. Bierman HR. Some problems of anti-neoplastic chemotherapy. Proceedings of the Western Pharmacology Society 1961; 4:13.
    6. Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P at al. Randomized comparison of cisplatin plus fl uorouracil and carboplatin plus fl uorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study Journal of Clinical Oncology 1992; 10(8):124551. Go to original source... Go to PubMed...
    7. Grandis JR, Pietenpol JA, Greenberger JS, Pelroy RA, Mohla S. Head and neck cancer: meeting summary and research opportunities. Cancer Research 2004; 64(21):81269. Go to original source... Go to PubMed...
    8. Greenberg B, Ahmann F, Garewal H, Koopmann C, Coulthard S et al. Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fl uorouracil and cisplatin. A phase I-II study. Cancer 1987; 59(11):18605. Go to original source... Go to PubMed...
    9. Greenberg BR. Chemotherapy of squamous cell carcinoma of the head and neck. Arizona Medicine 1985; 42(7):4117.
    10. Hussain M, Benedetti J, Smith RE, Rodriguez GI, Schuller D, Ensley J. Evaluation of 96-hour infusion fl uorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. Cancer 1995; 76(7):12337. Go to original source... Go to PubMed...
    11. Jacobs JR, Weaver A, Ahmed K, Crissman J, Ensley JF, Kish JA. Cummings G. al-Sarraf M. Proto-chemotherapy in advanced head and neck cancer. Head & Neck Surgery 1987; 10(2):938. Go to original source... Go to PubMed...
    12. Jassem J, Gyergyay F, Kerpel-Fronius S, Nagykalnai T, Baumohl J, Verweij J et al. Combination of daily 4-h infusion of 5-fl uorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group study. Cancer Chemotherapy & Pharmacology 1993; 31(6):489 94. Go to original source... Go to PubMed...
    13. Kish JA, Ensley JF, Jacobs JR, Binns P, al-Sarraf M. Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer. American Journal of Clinical Oncology 1988; 11(5):5537. Go to original source... Go to PubMed...
    14. Klopp CT, Alford TC, Bateman J, Berry GN, Winship T. Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report. Annals of Surgery 1950; 132(4):81132. Go to original source... Go to PubMed...
    15. Kostrica R, Smilek P, Hlozek J, Spurny V, Mechl Z. Soucasna komplexni lecba nadoru krku, MU v Brne, LF, edice kontinualniho vzdelavani v medicine 2003.
    16. Pai VR, Parikh DM, Mazumdar AT, Rao RS. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck. Oncology 1993; 50(2):8691. Go to original source... Go to PubMed...
    17. Papadimitrakopoulou VA, Ginsberg LE, Garden AS, Kies MS, Glisson BS, Diaz EM Jr et al. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer 2003; 98(10):221423. Go to original source... Go to PubMed...
    18. Poulsen M, Aldren Ch, Tripcony L, Walker Q. Is Surgery Necessary in Stage III and Stage IV Cancer of the Head and Neck That Responds to Induction Chemotherapy? Archives of Otolaryngology Head & Neck Surgery 1996; 122(5):467471. Go to original source... Go to PubMed...
    19. Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki et al. Cisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Advanced Head and Neck Cancer: Long-Term Follow-Up. Journal of Clinical Oncology 2004; 22(15):30613069. Go to original source... Go to PubMed...
    20. Psyrri A, Fountzilas G. Advances in the Treatment of Locally Advanced Non-Nasopharyngeal Squamous Cell Carcinoma of the Head and Neck Region. Medical Oncology 2006; 23(1):115. Go to original source...
    21. Schuller DE, Laramore G, Al-Sarraf M, Jacobs J, Pajak TF. Combined therapy for resectable head and neck cancer. A phase 3 intergroup study. Multicenter Study. Randomized Archives of Otolaryngology Head & Neck Surgery 1989; 115(3):3648. Go to original source... Go to PubMed...
    22. Smilek P, Kostřica R, Spurný V, Mechl Z. Maligní nádory hlavy a krku Diagnostické a léčebné postupy u maligních chorob 2004; 2739.
    23. Spaulding M, Ziegler P, Sundquist N, Klotch D, Lee K, Khan A, Lore J. Induction therapy in head and neck cancer. A comparison of two regiment,Cancer 1986; 57(6):11104. Go to original source... Go to PubMed...
    24. Spurný V, Mechl Z, Červená R. Současné možnosti chemoterapie nádorů oblasti hlavy a krku. Klinická onkologie 2003; 16:1018.
    25. Sullivan RD, Watkins E Jr. Cancer chemotherapy by protracted arterial infusion. Arizona Medicine 1965; 22(10):7916.
    26. Sullivan RD, Watkins E Jr. Protractedarterial infusion cancer chemotherapy, Acta Unio Internationalis Contra Cancrum 1964; 20:4803.
    27. Sullivan RD, Miller E, Sikes MP. Antimetabolite-metabolite combination cancer chemotherapy. Eff ects of intraarterial methotrexateintramuscular Citrovorum factor therapy in human cancer. Cancer 1959; 12:124862. Go to original source... Go to PubMed...
    28. Sullivan RD. Continuous arterial infusion cancer chemotherapy. Rhode Island Medical Journal 1961; 44:5816.
    29. Sullivan RD, Watkins E Jr. Cancer chemotherapy by protracted arterial infusion. Arizona Medicine 1965; 22(10):7916.
    30. Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ et al. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. Journal of Clinical Oncology 2006; 24(25):41639. Go to original source... Go to PubMed...
    31. Verweij J, de Jong P, Mulder P, van der Broek P, Alexieva-Figusch J, van Putten W et al. Induction Chemotherapy with Cisplatin and Continuous Infusion 5-Fluorouracil in Locally Far-Advanced Head and Neck Cancer. American Journal of Clinical Oncology 1989; 12(5):420424. Go to original source... Go to PubMed...
    32. Wong ASC, Soo RA, Lu JJ, Loh KS, Tan KS, Hsieh WS et al. Paclitaxel, 5-fl uorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma. ,Annals of Oncology 2006; 17(7):11521157. Go to original source... Go to PubMed...

    Return to the content